{"id":67,"date":"2017-08-31T10:01:37","date_gmt":"2017-08-31T07:01:37","guid":{"rendered":"http:\/\/icg.nsc.ru\/encephalitis\/?page_id=27"},"modified":"2017-08-31T10:01:37","modified_gmt":"2017-08-31T07:01:37","slug":"allelic-variant","status":"publish","type":"page","link":"https:\/\/sites.icgbio.ru\/TBEVHostDB\/allelic-variant\/","title":{"rendered":"Allelic variant in this gene was associated with susceptibility or resistance to TBEV infection"},"content":{"rendered":"<p>All genes were collected from research papers.<\/p>\n<table width=\"auto\">\n<tbody>\n<tr>\n<th>EntrezGene<br \/>Official<br \/>Symbol<\/th>\n<th>Official Full Name<\/th>\n<th>EntrezGene<br \/>Gene ID<\/th>\n<th>Also<br \/>known as<\/th>\n<th>SNP ID<\/th>\n<th>Reference<\/th>\n<th>PMID<\/th>\n<th>SNP location<\/th>\n<th>Population<\/th>\n<th>Phenotypic trait caused by allelic variants<\/th>\n<\/tr>\n<tr>\n<td><em>ARID1B<\/em><\/td>\n<td>AT-rich interaction domain 1B<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/57492\" target=\"_blank\" rel=\"noopener\">57492<\/a><\/td>\n<td><\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=287886\" target=\"_blank\" rel=\"noopener\">rs287886<\/a><\/td>\n<td>[Grygorczuk S et al., 2015]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=25461389\" target=\"_blank\" rel=\"noopener\">25461389<\/a><\/td>\n<td>ARID1B,\u00a0 first intron<\/td>\n<td>Polish population<\/td>\n<td>IL-10 concentration in CSF in TBE patients [Grygorczuk S et al., 2015]<\/td>\n<\/tr>\n<tr>\n<td><em>CCR5<\/em><\/td>\n<td>C-C motif chemokine receptor 5 (gene\/pseudogene)<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/1234\" target=\"_blank\" rel=\"noopener\">1234<\/a><\/td>\n<td><\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=333\" target=\"_blank\" rel=\"noopener\">rs333 (CCR5D32)<\/a><\/td>\n<td>[Mickien\u0117 A\u00a0 et al., 2014] [Kindberg E et al., 2008]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=25226020\" target=\"_blank\" rel=\"noopener\">25226020<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=18179389\" target=\"_blank\" rel=\"noopener\">18179389<\/a><\/td>\n<td>CCR5, exon 1 or 2<\/td>\n<td>Lithuanian Population<\/td>\n<td>The prevalence of CCR5D32 homozygotes was higher in TBE patients than in controls (p,0.05) [Mickien\u0117 A et al., 2014]. CCR5 32 allele prevalence increased with the clinical severity of disease\u00a0 [Kindberg E et al., 2008]<\/td>\n<\/tr>\n<tr>\n<td><em>CD209<\/em><\/td>\n<td>CD209 molecule<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/30835\" target=\"_blank\" rel=\"noopener\">30835<\/a><\/td>\n<td><\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=2287886\" target=\"_blank\" rel=\"noopener\">rs2287886<\/a><\/td>\n<td>[Barkhash AV et al., 2012]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=22061615\" target=\"_blank\" rel=\"noopener\">22061615<\/a><\/td>\n<td>CD209, promoter region<\/td>\n<td>Russian population<\/td>\n<td>Predisposition to severe forms of TBE in the Russian population [Barkhash AV et al., 2012]<\/td>\n<\/tr>\n<tr>\n<td rowspan=\"2\"><em>IFNL3<\/em><\/td>\n<td rowspan=\"2\">interferon lambda 3<\/td>\n<td rowspan=\"2\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/282617\" target=\"_blank\" rel=\"noopener\">282617<\/a><\/td>\n<td rowspan=\"2\">IL28B<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=8103142\" target=\"_blank\" rel=\"noopener\">rs8103142<\/a><\/td>\n<td>[Barkhash AV et al. 2016]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=27068548\" target=\"_blank\" rel=\"noopener\">27068548<\/a><\/td>\n<td>IFNL3, exon 2, Lys70Arg or exon 3, Lys74Arg<\/td>\n<td>Russian population from Novosibirsk<\/td>\n<td>Predisposition to TBE in Russian population [Barkhash AV et al. 2016]<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=12980275\" target=\"_blank\" rel=\"noopener\">rs12980275<\/a><\/td>\n<td>[Barkhash AV et al. 2016]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=27068548\" target=\"_blank\" rel=\"noopener\">27068548<\/a><\/td>\n<td>IFNL3,\u00a0 3&#8242;-flanking region<\/td>\n<td>Russian population from Novosibirsk<\/td>\n<td>Predisposition to TBE in Russian population [Barkhash AV et al. 2016]<\/td>\n<\/tr>\n<tr>\n<td><em>IFNL4<\/em><\/td>\n<td>interferon lambda 4 (gene\/pseudogene)<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/101180976\" target=\"_blank\" rel=\"noopener\">101180976<\/a><\/td>\n<td><\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=12979860\" target=\"_blank\" rel=\"noopener\">rs12979860<\/a><\/td>\n<td>[Grygorczuk S et al., 2015]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=25461389\" target=\"_blank\" rel=\"noopener\">25461389<\/a><\/td>\n<td>IFNL4, first intron<\/td>\n<td>Polish population<\/td>\n<td>IFNL3 concentration in CSF in TBE patients [Grygorczuk S et al., 2015]<\/td>\n<\/tr>\n<tr>\n<td><em>IL10<\/em><\/td>\n<td>interleukin 10<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/3586\" target=\"_blank\" rel=\"noopener\">3586<\/a><\/td>\n<td><\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=1800872\" target=\"_blank\" rel=\"noopener\">rs1800872<\/a><\/td>\n<td>[Barkhash AV et al. 2016]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=27068548\" target=\"_blank\" rel=\"noopener\">27068548<\/a><\/td>\n<td>IL10, promoter region<\/td>\n<td>Russian population from Novosibirsk<\/td>\n<td>Predisposition to TBE in Russian population [Barkhash AV et al. 2016]<\/td>\n<\/tr>\n<tr>\n<td rowspan=\"3\"><em>OAS2<\/em><\/td>\n<td rowspan=\"3\">2&#8242;-5&#8242;-oligoadenylate synthetase 2<\/td>\n<td rowspan=\"3\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/4939\" target=\"_blank\" rel=\"noopener\">4939<\/a><\/td>\n<td rowspan=\"3\"><\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=1293762\" target=\"_blank\" rel=\"noopener\">rs1293762<\/a><\/td>\n<td>[Barkhash AV et al., 2010]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=21050126\" target=\"_blank\" rel=\"noopener\">21050126<\/a><\/td>\n<td>OAS2, intron 2<\/td>\n<td>Russian population from Novosibirsk<\/td>\n<td>The outcome of tickborne encephalitis virus infection in a Russian population [Barkhash AV et al., 2010]<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=15895\" target=\"_blank\" rel=\"noopener\">rs15895<\/a><\/td>\n<td>[Barkhash AV et al., 2010]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=21050126\" target=\"_blank\" rel=\"noopener\">21050126<\/a><\/td>\n<td>OAS2, 3&#8242;-UTR \/ exon 11, Trp720Stop<\/td>\n<td>Russian population from Novosibirsk<\/td>\n<td>The outcome of tickborne encephalitis virus infection in a Russian population [Barkhash AV et al., 2010]<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=1732778\" target=\"_blank\" rel=\"noopener\">rs1732778<\/a><\/td>\n<td>[Barkhash AV et al., 2010]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=21050126\" target=\"_blank\" rel=\"noopener\">21050126<\/a><\/td>\n<td>OAS2, 3&#8242;-flanking region<\/td>\n<td>Russian population from Novosibirsk<\/td>\n<td>The outcome of tickborne encephalitis virus infection in a Russian population [Barkhash AV et al., 2010]<\/td>\n<\/tr>\n<tr>\n<td rowspan=\"2\"><em>OAS3<\/em><\/td>\n<td rowspan=\"2\">2&#8242;-5&#8242;-oligoadenylate synthetase 3<\/td>\n<td rowspan=\"2\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/4940\" target=\"_blank\" rel=\"noopener\">4940<\/a><\/td>\n<td rowspan=\"2\"><\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=2285932\" target=\"_blank\" rel=\"noopener\">rs2285932<\/a><\/td>\n<td>[Barkhash AV et al., 2010]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=21050126\" target=\"_blank\" rel=\"noopener\">21050126<\/a><\/td>\n<td>OAS3, exon 6, Ile438Ile<\/td>\n<td>Russian population from Novosibirsk<\/td>\n<td>The outcome of tickborne encephalitis virus infection in a Russian population [Barkhash AV et al., 2010]<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=2072136\" target=\"_blank\" rel=\"noopener\">rs2072136<\/a><\/td>\n<td>[Barkhash AV et al., 2010]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=21050126\" target=\"_blank\" rel=\"noopener\">21050126<\/a><\/td>\n<td>OAS3, exon 8, Ser567Ser<\/td>\n<td>Russian population from Novosibirsk<\/td>\n<td>The outcome of tickborne encephalitis virus infection in a Russian population [Barkhash AV et al., 2010]<\/td>\n<\/tr>\n<tr>\n<td><em>TLR3<\/em><\/td>\n<td>toll like receptor 3<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/7098\" target=\"_blank\" rel=\"noopener\">7098<\/a><\/td>\n<td><\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=3775291\" target=\"_blank\" rel=\"noopener\">rs3775291<\/a><\/td>\n<td>[Mickien\u0117 A\u00a0 et al., 2014], [Barkhash AV et al., 2013]<\/td>\n<td><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=25226020\" target=\"_blank\" rel=\"noopener\">25226020<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=23721942\" target=\"_blank\" rel=\"noopener\">23721942<\/a><\/td>\n<td>TLR3, exon 4, Leu412Phe<\/td>\n<td>Russian population from Novosibirsk, Lithuanian Population<\/td>\n<td>Disease severity in adult [Mickien\u0117 A\u00a0 et al., 2014]<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>All genes were collected from research papers. EntrezGeneOfficialSymbol Official Full Name EntrezGeneGene ID Alsoknown as SNP ID Reference PMID SNP location Population Phenotypic trait caused by allelic variants ARID1B AT-rich interaction domain 1B 57492 rs287886 [Grygorczuk S et al., 2015] 25461389 ARID1B,\u00a0 first intron Polish population IL-10 concentration in CSF in TBE patients [Grygorczuk S&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/sites.icgbio.ru\/TBEVHostDB\/wp-json\/wp\/v2\/pages\/67"}],"collection":[{"href":"https:\/\/sites.icgbio.ru\/TBEVHostDB\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.icgbio.ru\/TBEVHostDB\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.icgbio.ru\/TBEVHostDB\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.icgbio.ru\/TBEVHostDB\/wp-json\/wp\/v2\/comments?post=67"}],"version-history":[{"count":0,"href":"https:\/\/sites.icgbio.ru\/TBEVHostDB\/wp-json\/wp\/v2\/pages\/67\/revisions"}],"wp:attachment":[{"href":"https:\/\/sites.icgbio.ru\/TBEVHostDB\/wp-json\/wp\/v2\/media?parent=67"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}